Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Langdon

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
British Journal of Cancer|June 1, 1991
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferonS P Langdon, G J Rabiasz, L Anderson, et al.
British Journal of Cancer|May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancerA H Sims, A J M Zweemer, Y Nagumo, et al.
Cancer Research|November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell linesS P Langdon, S S Lawrie, F G Hay, et al.
British Journal of Cancer|March 31, 1999
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868B J Simpson, J M Bartlett, K G Macleod, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Estrogen regulation of transforming growth factor-alpha in ovarian cancerB J Simpson, S P Langdon, G J Rabiasz, et al.
British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
British Journal of Cancer|June 1, 1991
Characterisation and properties of a small cell lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferonS P Langdon, G J Rabiasz, L Anderson, et al.
British Journal of Cancer|May 3, 2012
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancerA H Sims, A J M Zweemer, Y Nagumo, et al.
Cancer Research|November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell linesS P Langdon, S S Lawrie, F G Hay, et al.
British Journal of Cancer|March 31, 1999
Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868B J Simpson, J M Bartlett, K G Macleod, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Estrogen regulation of transforming growth factor-alpha in ovarian cancerB J Simpson, S P Langdon, G J Rabiasz, et al.
British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.
Pageof 8